Keyphrases
Interleukin-12 (IL-12)
100%
Cryoimmunotherapy
100%
Cryoablation
66%
Lung Cancer
44%
Cryo
44%
Collagen Binding
33%
Immune Cells
33%
Tumor Cells
33%
Immune System
33%
Tumor
33%
Collagen
33%
Lung Tumor
22%
Lung Cancer Patients
22%
Surgical Resection
22%
Primary Tumor
22%
Novel Molecules
11%
Recurrent Tumor
11%
Tumor Recurrence
11%
Structural Proteins
11%
Military Veterans
11%
Patrolling
11%
Early-stage Lung Cancer
11%
Smoking Exposure
11%
Stage I Disease
11%
Effector Immune Cells
11%
Left behind
11%
Liquefied Gas
11%
Carcinogen
11%
Clinically Significant
11%
Surgical Alternative
11%
Immune Response
11%
Metastasis
11%
Surgical Removal
11%
Adjuvant Therapy
11%
Cancer Center
11%
Cryoprobe
11%
Interleukin
11%
Hospital Stay
11%
Master Regulator
11%
Large Animal Model
11%
Occupational Exposure
11%
Cancer Therapy
11%
Survival Rate
11%
Current Treatment
11%
Lung Cancer Cells
11%
Coin Flip
11%
Patient Recovery
11%
Attack Target
11%
Effective Therapy
11%
Tumor Model
11%
Combination Immunotherapy
11%
Liquefied Nitrogen
11%
Argon
11%
Systemic Circulation
11%
Suppressing Cell
11%
Antitumor Immune Response
11%
Immune Stimulation
11%
Protein Fragments
11%
Military Personnel
11%
Minimally Invasive
11%
Treatment Strategy
11%
Translational Studies
11%
Medical Center
11%
State Colleges
11%
Defense Mechanisms
11%
Lung Metastasis
11%
Humanized
11%
Patient's Will
11%
Combined Method
11%
Veterinary Medicine
11%
High Risk
11%
Clinical Trial Development
11%
Medicine and Dentistry
Interleukin 12
100%
Lung Cancer
88%
Cryoablation
66%
Immunotherapy
55%
Immunocompetent Cell
44%
Neoplasm
33%
Tumor Cell
33%
Tumor Recurrence
22%
Lung Tumor
22%
Immune Response
22%
Surgery
22%
Metastatic Carcinoma
22%
Primary Tumor
22%
Immune System
22%
Adjuvant Therapy
11%
Systemic Circulation
11%
Medicine
11%
Recurrent Disease
11%
Clinical Trial
11%
Disease
11%
Occupational Exposure
11%
Carcinogen
11%
Cancer Therapy
11%
Tumor Model
11%
Survival Rate
11%
Structural Protein
11%
Interleukin Derivative
11%
Cells of the Immune System
11%
Malignant Neoplasm
11%
Cancer Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 12
100%
Lung Cancer
88%
Neoplasm
66%
Immunotherapy
55%
Malignant Neoplasm
22%
Tumor Recurrence
22%
Lung Tumor
22%
Primary Tumor
22%
Metastasis
11%
Structural Protein
11%
Tumor Model
11%
Interleukin Derivative
11%
Systemic Circulation
11%
Carcinogen
11%
Occupational Exposure
11%
Clinical Trial
11%
Disease
11%
Survival Rate
11%
Recurrent Disease
11%